세계의 신경 조절 시장 : 기술별, 용도별 예측(2025-2030년)

The Neuromodulation Market was valued at USD 7.76 billion in 2023, expected to reach USD 8.61 billion in 2024, and is projected to grow at a CAGR of 11.50%, to USD 16.62 billion by 2030.

Neuromodulation, a pioneering domain in the medical field, encompasses technologies and methodologies that directly act upon nerves to achieve a therapeutic effect, thus altering nerve activity through targeted delivery of electrical stimulation or pharmaceutical agents. Its necessity arises from rising neurological disorders, chronic pain syndromes, and an aging population, creating an imperative for effective management solutions. The application spectrum includes chronic pain management, epilepsy, Parkinson's disease, depression, and targeted muscle disorders. End-use scenarios often feature hospitals, clinics, and in-home care settings that leverage spinal cord stimulators, vagus nerve stimulators, and deep brain stimulators. Market dynamics reveal key influencers such as technological advancements, increasing patient awareness, and heightened healthcare expenditure which boost growth. The escalation of minimally invasive surgeries offers lucrative potential and marks a frontier for new market entrants. Furthermore, emergent economies with improving healthcare frameworks present untapped opportunities. However, limitations such as high device costs, complex regulatory environments, and potential side effects restrict rapid market expansion. Challenges also stem from first-mover advantages held by established players, inhibiting newer entrants. Innovatively, wearable neuromodulators and AI-driven personalization of treatment regimens highlight fertile research avenues poised to disrupt traditional practices. Additionally, the integration of IoT for remote monitoring in neural applications could redefine patient interactions and outcomes. The market holds a dynamic yet conservative nature, where nimbleness in product development and strategic partnerships is critical to captivate market share. Businesses are encouraged to invest in robust R&D initiatives that align with regulatory compliances to harness these opportunities, emphasizing collaborations with tech firms to integrate digital advancements. Overall, while the neuromodulation market faces hurdles, its vast potential lies in bridging innovative solutions with clinical efficacy for sustained business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neuromodulation Market

The Neuromodulation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in the aging population across the world and prevalence of neurological disorders
  • Research initiatives and clinical trials for neurostimulation systems and neuromodulation solutions
  • Government initiatives to expand access to therapies for neurological diseases and disorders
• Market Restraints
  • Incidences of product recall of neuromodulation and neurostimulation devices or systems
• Market Opportunities
  • Innovations to optimize the efficiency and safety of neuromodulation strategies
  • Ongoing approvals for neuromodulation devices and treatments across the world
• Market Challenges
  • Invasiveness and technical limitations of the technology

Porter's Five Forces: A Strategic Tool for Navigating the Neuromodulation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neuromodulation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neuromodulation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neuromodulation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neuromodulation Market

A detailed market share analysis in the Neuromodulation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neuromodulation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neuromodulation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neuromodulation Market

A strategic analysis of the Neuromodulation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neuromodulation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BioControl by Merck, BioElectronics Corporation, Boston Scientific Corporation, Dr Reddys Laboratories Limited, EndoStim, Inc., Galderma S.A., GrayMatters Health, Impulse Dynamics, Livanova, Mainstay Medical, Medtronic PLC, MicroTransponde, NeuroMetrix, Neuronetics, Inc., NeuroPace, Inc., NeuroSigma, Inc., Nevro Corp., Saluda Medical, SceneRay Corporation, Limited, Soterix Medical, and Synapse Biomedical.

Market Segmentation & Coverage

This research report categorizes the Neuromodulation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Deep Brain Stimulation, Gastric Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, and Vagus Nerve Stimulation.
• Based on Application, market is studied across Chronic Pain, Dystonia, Essential Tremor, Gastroparesis, Obsessive Compulsive Disorder, Parkinson's Disease, Refractory Epilepsy, Treatment Resistant Depression, and Urinary Fecal Incontinence.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in the aging population across the world and prevalence of neurological disorders
    • 5.1.1.2. Research initiatives and clinical trials for neurostimulation systems and neuromodulation solutions
    • 5.1.1.3. Government initiatives to expand access to therapies for neurological diseases and disorders
  • 5.1.2. Restraints
    • 5.1.2.1. Incidences of product recall of neuromodulation and neurostimulation devices or systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations to optimize the efficiency and safety of neuromodulation strategies
    • 5.1.3.2. Ongoing approvals for neuromodulation devices and treatments across the world
  • 5.1.4. Challenges
    • 5.1.4.1. Invasiveness and technical limitations of the technology
• 5.2. Market Segmentation Analysis
  • 5.2.1. Technology: Increasing need for deep brain stimulation therapies for movement disorders and psychiatric issues
  • 5.2.2. Application: Rising incidences of Parkinson's disease across the world
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neuromodulation Market, by Technology

• 6.1. Introduction
• 6.2. Deep Brain Stimulation
• 6.3. Gastric Stimulation
• 6.4. Sacral Nerve Stimulation
• 6.5. Spinal Cord Stimulation
• 6.6. Vagus Nerve Stimulation

7. Neuromodulation Market, by Application

• 7.1. Introduction
• 7.2. Chronic Pain
• 7.3. Dystonia
• 7.4. Essential Tremor
• 7.5. Gastroparesis
• 7.6. Obsessive Compulsive Disorder
• 7.7. Parkinson's Disease
• 7.8. Refractory Epilepsy
• 7.9. Treatment Resistant Depression
• 7.10. Urinary Fecal Incontinence

8. Americas Neuromodulation Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Neuromodulation Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Neuromodulation Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. GrayMatters Health Launches New FDA-Cleared Self-Neuromodulation PTSD Therapy in the United States
  • 11.3.2. Dr. Reddy's Unveils Wearable for Migraine Management in India
  • 11.3.3. Galderma Unveils Bold Ambition in Neuromodulation at Liquid Live Event
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. BioControl by Merck
• 3. BioElectronics Corporation
• 4. Boston Scientific Corporation
• 5. Dr Reddys Laboratories Limited
• 6. EndoStim, Inc.
• 7. Galderma S.A.
• 8. GrayMatters Health
• 9. Impulse Dynamics
• 10. Livanova
• 11. Mainstay Medical
• 12. Medtronic PLC
• 13. MicroTransponde
• 14. NeuroMetrix
• 15. Neuronetics, Inc.
• 16. NeuroPace, Inc.
• 17. NeuroSigma, Inc.
• 18. Nevro Corp.
• 19. Saluda Medical
• 20. SceneRay Corporation, Limited
• 21. Soterix Medical
• 22. Synapse Biomedical